BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
229.50-6.99 (-2.96%)
At close: 4:00PM EDT
232.01 +2.51 (1.09%)
Pre-market: 08:48AM EDT
Pre-market: 08:48AM EDT
| Previous close | 236.49 |
| Open | 233.88 |
| Bid | 230.00 x 800 |
| Ask | 232.80 x 900 |
| Day's range | 219.70 - 238.00 |
| 52-week range | 53.52 - 252.78 |
| Volume | 2,701,400 |
| Avg. volume | 3,071,531 |
| Market cap | 55.429B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 09 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 194.62 |
- Editor's pickYahoo Finance Video
‘Vaccination is very effective against the Delta variant’: Doctor
Dr. Shereef Elnahal, University Hospital CEO and former NJDOH Commissioner, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
- Yahoo Finance UK
mRNA vaccine-makers’ stocks take a hit amid possible link to rare heart conditions
There could be a 'likely association' between adolescents getting the vaccines and cases of myocarditis and pericarditis.
- Motley Fool
Why Moderna and BioNTech Stocks Slipped Today
Data was presented to a CDC advisory panel suggesting a link between mRNA vaccines and heart inflammation issues in young men.
© 2021 Verizon Media. All rights reserved.
